Research.Patient.info
PARKINSON DISEASE (Disorder) research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE1, PHASE2
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
This study is testing a new medicine, IRL757, for people with Parkinson's disease who also have apathy (a lack of interest or drive). Researchers want to see if the medicine is safe, well-tolerated, and if it helps with Parkinson's symptoms. Some people will get the real medicine, others a dummy pill.
Bulgaria · Germany · Poland - recruitingPHASE1
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
This study is looking at psilocybin-assisted therapy for cancer patients feeling very down or losing hope. It wants to see if this treatment is safe and helps improve their emotional well-being.
Canada - recruitingPHASE1
Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
This study is testing a new medicine, RCS-21, in healthy volunteers to see if it's safe and how it acts in the body. Participants will inhale a single dose and be carefully monitored.
Germany